Spectrum has had a really nice run the last year. The recent small pullback was to be expected. In my opinion, the uptrend channel will continue to stay very healthy for all the fundamental reasons I have listed in this article.
Meta Keywords:
biopharma biotech pharma health cancer
Meta Description:
Spectrum has had a really nice run the last year. The recent small pullback was to be expected. In my opinion, the uptrend channel will continue to stay very healthy for all the fundamental reasons I have listed in this article.
